atrophic vaginitis/progesterone

Linkul este salvat în clipboard

Alegeți tipul de sortare

Pagină 1 din 35 rezultate

Ex Vivo Evaluation of Intravaginal Progesterone and Testosterone to Treat the Luteal-phase Deficiency and Vaginal Atrophy.

Numai utilizatorii înregistrați pot traduce articole

The purpose of this study was to evaluate the transmucosal permeation of progesterone and testosterone using Pentravan as its vehicle for vaginal delivery. Progesterone deficiency is a hormone imbalance that could lead to luteal-phase deficiency, which is a common problem in assisted reproductive

Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis.

Numai utilizatorii înregistrați pot traduce articole

OBJECTIVE The aim of this study was to assess the efficacy and safety of intravaginal estriol and progesterone on atrophic vaginitis in postmenopausal women. METHODS Under a physician-sponsored Investigational New Drug application, 19 healthy postmenopausal women with atrophic vaginitis received

Vaginal stromal sclerosis: a distinctive stromal change associated with vaginal atrophy.

Numai utilizatorii înregistrați pot traduce articole

The author describes 3 cases of an unusual vaginal lesion, designated as "vaginal stromal sclerosis," that is believed to represent a clinically and pathologically distinct disease. The 3 patients, aged 62, 52, and 50 years, all presented with dyspareunia and had clinical evidence of vaginal

Treatment of menopausal symptoms with three low-dose continuous sequential 17β-estradiol/progesterone parenteral monthly formulations using novel non-polymeric microsphere technology.

Numai utilizatorii înregistrați pot traduce articole

OBJECTIVE To analyze the short-term efficacy and safety over menopausal symptoms of three low-dose continuous sequential 17β-estradiol (E)/progesterone (P) parental monthly formulations using novel non-polymeric microspheres. METHODS This was a multicenter, randomized, single blinded study in which

A comparison of raloxifene and calcium plus vitamin D on vaginal atrophy after discontinuation of long-standing postmenopausal hormone therapy in osteoporotic women. A randomized, masked-evaluator, one-year, prospective study.

Numai utilizatorii înregistrați pot traduce articole

OBJECTIVE We assessed the effects of the discontinuation of long-standing transdermal estrogen replacement therapy (>4 years) and substitution of this treatment by calcium or raloxifene on the vaginal epithelium and climateric symptoms in a study population of osteoporotic women. METHODS A total of

Topical progesterone in treatment of vulvar dystrophy: preliminary report of five cases.

Numai utilizatorii înregistrați pot traduce articole

Topical progesterone was used in five cases of chronic vulvar dystrophy which were confirmed by biopsy. Good results were obtained in three of the cases through the sole use of topical progesterone. In one case, topical testosterone was substituted for the progesterone, and it was not as effective.

Menopausal hormone replacement therapy with continuous daily oral micronized estradiol and progesterone.

Numai utilizatorii înregistrați pot traduce articole

The safety and efficacy of a daily combination of micronized estradiol (E2) (0.7-1.05 mg) and progesterone (200-300 mg) were evaluated in ten menopausal women with moderate to severe vasomotor symptoms and/or vaginal atrophy over a 12-month study interval. For comparison, five similar women were

Biopsychosocial predictors of postmenopausal dyspareunia: the role of steroid hormones, vulvovaginal atrophy, cognitive-emotional factors, and dyadic adjustment.

Numai utilizatorii înregistrați pot traduce articole

BACKGROUND Although dyspareunia experienced after menopause is widely attributed to declining estrogen levels and vulvovaginal atrophy, critical reviews of the literature have suggested that these factors are incomplete as explanatory mechanisms. Little is known about psychosocial factors that may

The role of hormone replacement therapy in women with a previous diagnosis of breast cancer and a review of possible alternatives.

Numai utilizatorii înregistrați pot traduce articole

Estrogen replacement therapy either with (HRT) or without (ERT) accompanying progesterone is routinely offered to well women at the time of menopause, in order to relieve vasomotor symptoms, (hot flashes), reduce urogenital atrophy and reduce the risks of cardiovascular disease, osteoporosis and

[Oestrogen for prevention of recurrent urinary tract infections in postmenopausal women--a survey of a Cochrane review].

Numai utilizatorii înregistrați pot traduce articole

Recurrent urinary tract infections (UTIs) are common in postmenopausal women. While the pathophysiology is often complex, it is evident that the urogenital atrophy due to the decrease of endogenous oestrogen production is a key factor. Two small randomized controlled studies have proven the efficacy

Estrogens and the lower urinary tract.

Numai utilizatorii înregistrați pot traduce articole

The urogenital tract is sensitive to the effect of oestrogen and progesterone throughout adult life. Epidemiological studies have implicated oestrogen deficiency in the aetiology of lower urinary tract symptoms occurring following the menopause. Although to date the role of oestrogen replacement

[Hormone therapy in menopause: when not to use].

Numai utilizatorii înregistrați pot traduce articole

Menopause is defined as the permanent cessation of menses, as a result of the loss of ovarian follicular function or of surgical removal of ovaries. The mean age for occurrence of natural menopause is around 50 years. Estrogen deficiency has been associated with vasomotor symptoms, urogenital

Psychosexual effects of menopause: role of androgens.

Numai utilizatorii înregistrați pot traduce articole

Ovarian hormones-estrogens, androgens, and progesterone-produce a myriad of effects in the nervous system. The effects of androgens in the brain are mediated through androgen-specific receptors and by the aromatization of testosterone to estradiol. Alterations in the circulating levels of androgens

Vaginal rings for menopausal symptom relief.

Numai utilizatorii înregistrați pot traduce articole

The vagina is an alternative delivery site of sex steroids for menopausal women. New ring technology provides continuous and consistent delivery of steroids for up to 3 months. Rings rest on the pelvic floor muscles in a nearly horizontal position and are usually imperceptible. Steroid is delivered

Progestogens in postmenopausal hormone therapy and the risk of breast cancer.

Numai utilizatorii înregistrați pot traduce articole

Hormone therapy is the treatment of choice for the alleviation of menopausal symptoms and the treatment of urogenital atrophy. In women with an intact uterus a progestogen must be added to estrogen therapy to prevent endometrial hyperplasia and cancer. There is a wide variety of marketed

Anterior
1
2
3
Următor →

Alăturați-vă paginii
noastre de facebook

Herbal & Natural Medicine

Cea mai completă bază de date cu plante medicinale susținută de știință

Funcționează în 55 de limbi
Cure pe bază de plante susținute de știință
Recunoașterea ierburilor după imagine
Harta GPS interactivă - etichetați ierburile în locație (în curând)
Citiți publicațiile științifice legate de căutarea dvs.
Căutați plante medicinale după efectele lor
Organizați-vă interesele și rămâneți la curent cu noutățile de cercetare, studiile clinice și brevetele

Tastați un simptom sau o boală și citiți despre plante care ar putea ajuta, tastați o plantă și vedeți boli și simptome împotriva cărora este folosit.
* Toate informațiile se bazează pe cercetări științifice publicate